jofinЖурнал инфектологииJournal Infectology2072-6732IPO “АIDSSPbR"10.22625/2072-6732-2021-13-1-5-12jofin-1171Research ArticleПроблемная статьяProblem articleCOVID-19: год вместеCOVID-19: One year togetherЛукашевА. Н.LukashevA. N.

Лукашев Александр Николаевич – директор Института медицинской паразитологии, тропических и трансмиссивных заболеваний им. Е.И. Марциновского, д.м.н., член-корреспондент РАН

Москвател.: 8 (499)245-35-78

Moscow

alexander_lukashev@hotmail.comПервый Московский государственный университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation202128032021131512Copyright © Лукашев А.Н., 20212021Лукашев А.Н.Lukashev A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.niidi.ru/jofin/article/view/1171

Пандемия новой респираторной инфекции COVID-19 стала одним из самых значительных событий в истории инфектологии за последние 100 лет. В статье рассматриваются основные этапы развития пандемии и борьбы с ней, наиболее актуальные вопросы, которые стояли перед медицинской наукой в этом году, успехи и ошибки систем здравоохранения и ученых, современное состояние проблемы и ближайшие перспективы.

The pandemic of COVID-19, a novel respiratory infection, has become one of the most significant events in the history of infectious diseases over the past 100 years. The article reviews the main stages in the development of a pandemic and the fight against it, the most appealing issued faced by medical science, the successes and mistakes of healthcare systems and researchers, the current state of the problem and the nearest prospects.

SARS-Cov-2COVID-19пандемияSARS-Cov-2COVID-19pandemicReferencesDüx A. et al. Measles virus and rinderpest virus divergence dated to the sixth century BCE // Science (80-. ). 2020. Vol. 368, № 6497.Düx A. et al. Measles virus and rinderpest virus divergence dated to the sixth century BCE // Science (80-. ). 2020. Vol. 368, № 6497.Troupin C. et al. Large-Scale Phylogenomic Analysis Reveals the Complex Evolutionary History of Rabies Virus in Multiple Carnivore Hosts // PLoS Pathog. 2016. Vol. 12, № 12.Troupin C. et al. Large-Scale Phylogenomic Analysis Reveals the Complex Evolutionary History of Rabies Virus in Multiple Carnivore Hosts // PLoS Pathog. 2016. Vol. 12, № 12.Karesh W.B. et al. Ecology of zoonoses: natural and unnatural histories // Lancet. 2012. Vol. 380, № 9857.Karesh W.B. et al. Ecology of zoonoses: natural and unnatural histories // Lancet. 2012. Vol. 380, № 9857.Menachery V.D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence // Nat. Med. 2015. Vol. 21, № 12.Menachery V.D. et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence // Nat. Med. 2015. Vol. 21, № 12.Corman V.M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR // Eurosurveillance. 2020. Vol. 25, № 3.Corman V.M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR // Eurosurveillance. 2020. Vol. 25, № 3.Braun J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 // Nature. 2020. Vol. 587, № 7833.Braun J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 // Nature. 2020. Vol. 587, № 7833.Tillett R.L. et al. Genomic evidence for reinfection with SARS-CoV-2: a case study // Lancet Infect. Dis. 2021. Vol. 21, № 1.Tillett R.L. et al. Genomic evidence for reinfection with SARS-CoV-2: a case study // Lancet Infect. Dis. 2021. Vol. 21, № 1.Galanti M., Shaman J. Direct Observation of Repeated Infections With Endemic Coronaviruses // J. Infect. Dis. 2020.Galanti M., Shaman J. Direct Observation of Repeated Infections With Endemic Coronaviruses // J. Infect. Dis. 2020.Veronese N. et al. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature // Front. Med. 2020. Vol. 7.Veronese N. et al. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature // Front. Med. 2020. Vol. 7.The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report // N. Engl. J. Med. 2020.The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report // N. Engl. J. Med. 2020.Paranjpe I. et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 // J. Am. Coll. Cardiol. 2020. Vol. 76, № 1.Paranjpe I. et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 // J. Am. Coll. Cardiol. 2020. Vol. 76, № 1.Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. 2020. https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizesmonoclonal-antibodies-treatment-covid-19.Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. 2020. https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizesmonoclonal-antibodies-treatment-covid-19.Joshi S. et al. Role of favipiravir in the treatment of COVID-19 // Int. J. Infect. Dis. 2021. Vol. 102.Joshi S. et al. Role of favipiravir in the treatment of COVID-19 // Int. J. Infect. Dis. 2021. Vol. 102.Beigel J.H. et al. Remdesivir for the Treatment of Covid-19 — Final Report // N. Engl. J. Med. 2020. Vol. 383, № 19.Beigel J.H. et al. Remdesivir for the Treatment of Covid-19 — Final Report // N. Engl. J. Med. 2020. Vol. 383, № 19.Krammer F. SARS-CoV-2 vaccines in development // Nature. 2020. Vol. 586, № 7830.Krammer F. SARS-CoV-2 vaccines in development // Nature. 2020. Vol. 586, № 7830.de Alwis R. et al. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development // EBioMedicine. 2020. Vol. 55.de Alwis R. et al. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development // EBioMedicine. 2020. Vol. 55.Rambaut A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations [Electronic resource] // Pre-print. 2020. URL: https://virological.org/t/preliminary-genomiccharacterisation-of-an-emergent-sars-cov-2-lineage-in-theuk-defined-by-a-novel-set-of-spike-mutations/563 (accessed: 09.01.2021).Rambaut A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations [Electronic resource] // Pre-print. 2020. URL: https://virological.org/t/preliminary-genomiccharacterisation-of-an-emergent-sars-cov-2-lineage-in-theuk-defined-by-a-novel-set-of-spike-mutations/563 (accessed: 09.01.2021).Oude Munnink B.B. et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans // Science (80-. ). 2021. Vol. 371, № 6525.Oude Munnink B.B. et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans // Science (80-. ). 2021. Vol. 371, № 6525.Sheahan T.P. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice // Sci. Transl. Med. 2020. Vol. 12, № 541.Sheahan T.P. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice // Sci. Transl. Med. 2020. Vol. 12, № 541.

The authors declare that there are no conflicts of interest present.